Can adding probiotics to standard concomitant drug treatment improve outcomes over standard treatment alone in adults and children with ulcerative colitis?

2020 ◽  
Author(s):  
Kurinchi Gurusamy
2017 ◽  
Vol 152 (5) ◽  
pp. S795
Author(s):  
Doron Schwartz ◽  
Batel Lasry ◽  
Moataz Abo Abod ◽  
Dan Greenberg ◽  
Michael Friger ◽  
...  

2003 ◽  
Vol 21 (2) ◽  
pp. 157-167 ◽  
Author(s):  
Paolo Gionchetti ◽  
Fernando Rizzello ◽  
Flavio Habal ◽  
Claudia Morselli ◽  
Cristina Amadini ◽  
...  

1979 ◽  
Vol 17 (3) ◽  
pp. 10-12

Sulphasalazine (Salazopyrin) and corticosteroids are the mainstay of drug treatment for proctocolitis (ulcerative colitis and proctitis). Sulphasalazine is particularly effective in maintaining the disease in remission, and corticosteroids in treating the acute attack. Nevertheless some patients with proctocolitis have frequent relapses or have symptoms which do not respond to these or other medical treatment, and occasional patients are hypersensitive to or intolerant of sulphasalazine. An oral preparation of sodium cromoglycate (SCG; Nalcrom - Fisons) has been developed in the hope that it would benefit some of these patients. It has also been tried in the treatment of food allergies.


Sign in / Sign up

Export Citation Format

Share Document